Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Tuberculosis

  Free Subscription


Articles published in Emerg Infect Dis

Retrieve available abstracts of 51 articles:
HTML format
Text format



Single Articles


    November 2017
  1. NATHAVITHARANA RR, Shi CX, Chindelevitch L, Calderon R, et al
    Polyclonal Pulmonary Tuberculosis Infections and Risk for Multidrug Resistance, Lima, Peru.
    Emerg Infect Dis. 2017;23:1887-1890.
    PubMed     Text format     Abstract available


  2. TAO NN, He XC, Zhang XX, Liu Y, et al
    Drug-Resistant Tuberculosis among Children, China, 2006-2015.
    Emerg Infect Dis. 2017;23:1800-1805.
    PubMed     Text format     Abstract available


    October 2017
  3. ACHAR J, Hewison C, Cavalheiro AP, Skrahina A, et al
    Off-Label Use of Bedaquiline in Children and Adolescents with Multidrug-Resistant Tuberculosis.
    Emerg Infect Dis. 2017;23.
    PubMed     Text format     Abstract available


  4. MARYANDYSHEV A, Pontali E, Tiberi S, Akkerman O, et al
    Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis.
    Emerg Infect Dis. 2017;23.
    PubMed     Text format     Abstract available


  5. JASPARD M, Elefant-Amoura E, Melonio I, De Montgolfier I, et al
    Bedaquiline and Linezolid for Extensively Drug-Resistant Tuberculosis in Pregnant Woman.
    Emerg Infect Dis. 2017;23.
    PubMed     Text format     Abstract available


    March 2017
  6. SETO J, Wada T, Suzuki Y, Ikeda T, et al
    Mycobacterium tuberculosis Transmission among Elderly Persons, Yamagata Prefecture, Japan, 2009-2015.
    Emerg Infect Dis. 2017;23:448-455.
    PubMed     Text format     Abstract available


  7. MALM S, Linguissi LS, Tekwu EM, Vouvoungui JC, et al
    New Mycobacterium tuberculosis Complex Sublineage, Brazzaville, Congo.
    Emerg Infect Dis. 2017;23:423-429.
    PubMed     Text format     Abstract available


  8. ADJEMIAN J, Frankland TB, Daida YG, Honda JR, et al
    Epidemiology of Nontuberculous Mycobacterial Lung Disease and Tuberculosis, Hawaii, USA.
    Emerg Infect Dis. 2017;23:439-447.
    PubMed     Text format     Abstract available


  9. SCOTT C, Cavanaugh JS, Silk BJ, Ershova J, et al
    Comparison of Sputum-Culture Conversion for Mycobacterium bovis and M. tuberculosis.
    Emerg Infect Dis. 2017;23:456-462.
    PubMed     Text format     Abstract available


  10. BOURDILLON PM, Goncalves CC, Pelissari DM, Arakaki-Sanchez D, et al
    Increase in Tuberculosis Cases among Prisoners, Brazil, 2009-20141.
    Emerg Infect Dis. 2017;23:496-499.
    PubMed     Text format     Abstract available


  11. SIMPSON G, Zimmerman R, Shashkina E, Chen L, et al
    Mycobacterium tuberculosis Infection among Asian Elephants in Captivity.
    Emerg Infect Dis. 2017;23:513-516.
    PubMed     Text format     Abstract available


  12. CHANDRANAIK BM, Shivashankar BP, Umashankar KS, Nandini P, et al
    Mycobacterium tuberculosis Infection in Free-Roaming Wild Asian Elephant.
    Emerg Infect Dis. 2017;23:555-557.
    PubMed     Text format     Abstract available


  13. BENOIT SR, Gregg EW, Jonnalagadda S, Phares CR, et al
    Association of Diabetes and Tuberculosis Disease among US-Bound Adult Refugees, 2009-2014.
    Emerg Infect Dis. 2017;23:543-545.
    PubMed     Text format     Abstract available


  14. ALLANA S, Shashkina E, Mathema B, Bablishvili N, et al
    pncA Gene Mutations Associated with Pyrazinamide Resistance in Drug-Resistant Tuberculosis, South Africa and Georgia.
    Emerg Infect Dis. 2017;23:491-495.
    PubMed     Text format     Abstract available


  15. ZACHARIAH A, Pandiyan J, Madhavilatha GK, Mundayoor S, et al
    Mycobacterium tuberculosis in Wild Asian Elephants, Southern India.
    Emerg Infect Dis. 2017;23:504-506.
    PubMed     Text format     Abstract available


    December 2016
  16. BARASONA JA, Acevedo P, Diez-Delgado I, Queiros J, et al
    Tuberculosis-Associated Death among Adult Wild Boars, Spain, 2009-2014.
    Emerg Infect Dis. 2016;22:2178-2180.
    PubMed     Text format     Abstract available


    September 2016
  17. KVASNOVSKY CL, Cegielski JP, van der Walt ML
    Treatment Outcomes for Patients with Extensively Drug-Resistant Tuberculosis, KwaZulu-Natal and Eastern Cape Provinces, South Africa.
    Emerg Infect Dis. 2016;22.
    PubMed     Text format     Abstract available


    June 2016
  18. MOKROUSOV I, Chernyaeva E, Vyazovaya A, Sinkov V, et al
    Next-Generation Sequencing of Mycobacterium tuberculosis.
    Emerg Infect Dis. 2016;22:1127-9.
    PubMed     Text format    


    March 2016
  19. STORY A, Garfein RS, Hayward A, Rusovich V, et al
    Monitoring Therapy Compliance of Tuberculosis Patients by using Video-Enabled Electronic Devices.
    Emerg Infect Dis. 2016;22.
    PubMed     Text format     Abstract available


  20. CLAASSENS MM, van Schalkwyk C, Dunbar R, Ayles H, et al
    Patient Diagnostic Rate as Indicator of Tuberculosis Case Detection, South Africa.
    Emerg Infect Dis. 2016;22.
    PubMed     Text format     Abstract available



  21. Preliminary Favorable Outcome for Medically and Surgically Managed Extensively Drug-Resistant Tuberculosis, France, 2009-2014.
    Emerg Infect Dis. 2016;22.
    PubMed     Text format     Abstract available


  22. THAPA J, Paudel S, Sadaula A, Shah Y, et al
    Mycobacterium orygis-Associated Tuberculosis in Free-Ranging Rhinoceros, Nepal, 2015.
    Emerg Infect Dis. 2016;22.
    PubMed     Text format    


  23. PEZZOLI L, Gounder S, Tamani T, Daulako MR, et al
    Tuberculosis, Fiji, 2002-2013.
    Emerg Infect Dis. 2016;22.
    PubMed     Text format     Abstract available


  24. TUPASI TE, Garfin AM, Kurbatova EV, Mangan JM, et al
    Factors Associated with Loss to Follow-up during Treatment for Multidrug-Resistant Tuberculosis, the Philippines, 2012-2014.
    Emerg Infect Dis. 2016;22.
    PubMed     Text format     Abstract available


  25. DIERBERG KL, Dorjee K, Salvo F, Cronin WA, et al
    Improved Detection of Tuberculosis and Multidrug-Resistant Tuberculosis among Tibetan Refugees, India.
    Emerg Infect Dis. 2016;22.
    PubMed     Text format     Abstract available


  26. BASAVARAJ A, Chandanwale A, Patil A, Kadam D, et al
    High Tuberculosis Risk among Medical Trainees, Pune, India.
    Emerg Infect Dis. 2016;22.
    PubMed     Text format     Abstract available


  27. SULLIVAN T, Ben Amor Y
    Global Introduction of New Multidrug-Resistant Tuberculosis Drugs-Balancing Regulation with Urgent Patient Needs.
    Emerg Infect Dis. 2016;22.
    PubMed     Text format     Abstract available


  28. STAGG HR, White PJ, Riekstina V, Cirule A, et al
    Decreased Time to Treatment Initiation for Multidrug-Resistant Tuberculosis Patients after Use of Xpert MTB/RIF Test, Latvia.
    Emerg Infect Dis. 2016;22.
    PubMed     Text format     Abstract available


  29. PARPIA AS, Ndeffo-Mbah ML, Wenzel NS, Galvani AP, et al
    Effects of Response to 2014-2015 Ebola Outbreak on Deaths from Malaria, HIV/AIDS, and Tuberculosis, West Africa.
    Emerg Infect Dis. 2016;22:433-41.
    PubMed     Text format     Abstract available


  30. TSCHAMPL CA, Garnick DW, Zuroweste E, Razavi M, et al
    Use of Transnational Services to Prevent Treatment Interruption in Tuberculosis-Infected Persons Who Leave the United States.
    Emerg Infect Dis. 2016;22:417-25.
    PubMed     Text format     Abstract available


  31. SHARMA A, Bloss E, Heilig CM, Click ES, et al
    Tuberculosis Caused by Mycobacterium africanum, United States, 2004-2013.
    Emerg Infect Dis. 2016;22:396-403.
    PubMed     Text format     Abstract available


  32. RAJU RM, Raju SM, Zhao Y, Rubin EJ, et al
    Leveraging Advances in Tuberculosis Diagnosis and Treatment to Address Nontuberculous Mycobacterial Disease.
    Emerg Infect Dis. 2016;22:365-9.
    PubMed     Text format     Abstract available


  33. FURIN J, Brigden G, Lessem E, Rich M, et al
    Global Progress and Challenges in Implementing New Medications for Treating Multidrug-Resistant Tuberculosis.
    Emerg Infect Dis. 2016;22.
    PubMed     Text format     Abstract available


  34. CHORBA T, Breedlove B
    Depictions of Heroism in Battle and Anguish from Tuberculosis.
    Emerg Infect Dis. 2016;22:573-4.
    PubMed     Text format    


    November 2015
  35. ERSHOVA JV, Volchenkov GV, Kaminski DA, Somova TR, et al
    Epidemiology of Primary Multidrug-Resistant Tuberculosis, Vladimir Region, Russia.
    Emerg Infect Dis. 2015;21:2048-51.
    PubMed     Text format     Abstract available


  36. ACHAR J, Berry C, Herboczek K, Parpieva N, et al
    Multidrug-Resistant Tuberculosis in Child Successfully Treated with 9-Month Drug Regimen.
    Emerg Infect Dis. 2015;21:2105-6.
    PubMed     Text format    


  37. PEREZ-LAGO L, Lirola MM, Navarro Y, Herranz M, et al
    Co-infection with Drug-Susceptible and Reactivated Latent Multidrug-Resistant Mycobacterium tuberculosis.
    Emerg Infect Dis. 2015;21:2098-100.
    PubMed     Text format    


  38. KIM JH, Yim JJ
    Achievements in and Challenges of Tuberculosis Control in South Korea.
    Emerg Infect Dis. 2015;21:1913-20.
    PubMed     Text format     Abstract available


    August 2015
  39. DOBLER CC, Korver S, Batbayar O, Nyamdulam B, et al
    Multidrug-Resistant Tuberculosis in Patients for Whom First-Line Treatment Failed, Mongolia, 2010-2011.
    Emerg Infect Dis. 2015;21:1451-1454.
    PubMed     Text format     Abstract available


  40. LIAO TL, Lin CH, Shen GH, Chang CL, et al
    Risk for Mycobacterial Disease among Patients with Rheumatoid Arthritis, Taiwan, 2001-2011.
    Emerg Infect Dis. 2015;21:1387-95.
    PubMed     Text format     Abstract available


    June 2015
  41. KEMPKER RR, Kipiani M, Mirtskhulava V, Tukvadze N, et al
    Acquired Drug Resistance in Mycobacterium tuberculosis and Poor Outcomes among Patients with Multidrug-Resistant Tuberculosis.
    Emerg Infect Dis. 2015;21:992-1001.
    PubMed     Text format     Abstract available


  42. SMITH SE, Ershova J, Vlasova N, Nikishova E, et al
    Risk Factors for Acquisition of Drug Resistance during Multidrug-Resistant Tuberculosis Treatment, Arkhangelsk Oblast, Russia, 2005-2010.
    Emerg Infect Dis. 2015;21:1002-11.
    PubMed     Text format     Abstract available


  43. KURBATOVA EV, Dalton T, Ershova J, Tupasi T, et al
    Additional drug resistance of multidrug-resistant tuberculosis in patients in 9 countries.
    Emerg Infect Dis. 2015;21:977-83.
    PubMed     Text format     Abstract available


  44. WILLIAMS OM, Abeel T, Casali N, Cohen K, et al
    Fatal nosocomial MDR TB identified through routine genetic analysis and whole-genome sequencing.
    Emerg Infect Dis. 2015;21:1082-4.
    PubMed     Text format    


  45. ACOSTA F, Chernyaeva E, Mendoza L, Sambrano D, et al
    Mycobacterium bovis in Panama, 2013.
    Emerg Infect Dis. 2015;21.
    PubMed     Text format     Abstract available


    March 2015
  46. TRIEU L, Proops DC, Ahuja SD
    Moxifloxacin Prophylaxis against MDR TB, New York, New York, USA.
    Emerg Infect Dis. 2015;21:500-3.
    PubMed     Text format     Abstract available


  47. CHIU NC, Lin MC, Lin WL, Wang SY, et al
    Mycobacterium bovis BCG-associated osteomyelitis/osteitis, Taiwan.
    Emerg Infect Dis. 2015;21:539-40.
    PubMed     Text format    


  48. MUSOKE J, Hlokwe T, Marcotty T, du Plessis BJ, et al
    Spillover of Mycobacterium bovis from wildlife to livestock, South Africa.
    Emerg Infect Dis. 2015;21:448-51.
    PubMed     Text format     Abstract available


  49. RAMDAS KE, Lyashchenko KP, Greenwald R, Robbe-Austerman S, et al
    Mycobacterium bovis infection in humans and cats in same household, Texas, USA, 2012.
    Emerg Infect Dis. 2015;21:480-3.
    PubMed     Text format     Abstract available


  50. GALLIVAN M, Shah N, Flood J
    Epidemiology of human Mycobacterium bovis disease, California, USA, 2003-2011.
    Emerg Infect Dis. 2015;21:435-43.
    PubMed     Text format     Abstract available


  51. THOMAS BS, Okamoto K
    Role of race/ethnicity in pulmonary nontuberculous mycobacterial disease.
    Emerg Infect Dis. 2015;21:544-5.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: